Do Biological Medicinal Products Pose a Risk to the Environment?: A Current View on Ecopharmacovigilance

Author： Kühler Thomas C.   Andersson Mikael   Carlin Gunnar   Johnsson Ann   Åkerblom Lennart  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.32, Iss.11, 2009-11, pp. : 995-1000

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Do antipsychotics increase the risk of death in dementia?

By  

Inpharma, Vol. 1, Iss. 1512, 2005-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Do antiepileptics increase the risk of suicidal acts?

By  

Reactions Weekly, Vol. 1, Iss. 1320, 2010-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Understanding and Communicating Key Concepts in Risk Management: What do we Mean by Benefit and Risk?

By Edwards I. Ralph   Lindquist Marie  

Drug Safety, Vol. 32, Iss. 6, 2009-05 ,pp. : 449-452

Adis International

Access to resources Recommend Favorite

Newer Biological Agents in the Treatment of Rheumatoid Arthritis: Do the Benefits Outweigh the Risks?

By Nurmohamed Michael T.  

Drugs, Vol. 69, Iss. 15, 2009-10 ,pp. : 2035-2043

Adis International

Access to resources Recommend Favorite

Risk of Melanoma with Psoralen/Ultraviolet A Therapy for Psoriasis: Do the Known Risks Now Outweigh the Benefits?

By Lindelöf B.  

Drug Safety, Vol. 20, Iss. 4, 1999-04 ,pp. : 289-297

Adis International

Access to resources Recommend Favorite